Moonlight Therapeutics is a pre‑clinical biotechnology company based in Atlanta, GA, focused on developing a novel intradermal therapy (MOON101) to treat peanut allergy. The company aims to create a best‑in‑class, differentiated desensitization treatment through animal‑model research and has secured private funding as well as a grant from the U.S. Defense Health Agency, with FDA IND clearance for its lead candidate.
No recent news for this company.